A Healthy Volunteer PK/PD, Safety and Tolerability Study of Andexanet After Betrixaban Dosing
Clinical trial NCT03330457 · TERMINATED
Trial details
- NCT number
- NCT03330457
- Sponsor
- Portola Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-06
- Primary completion
- 2016-02-22
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.